Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease

被引：0
|
作者：
Toshihito Otani
Kakuhiro Yamaguchi
Satoshi Nakao
Shinjiro Sakamoto
Yasushi Horimasu
Takeshi Masuda
Shintaro Miyamoto
Taku Nakashima
Hiroshi Iwamoto
Kazunori Fujitaka
Hironobu Hamada
Noboru Hattori
机构：
[1] Hiroshima University,Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences
[2] Mitsugi General Hospital,Department of Internal Medicine
[3] Hiroshima University,Department of Physical Analysis and Therapeutic Sciences, Graduate School of Biomedical and Health Sciences
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 88卷
关键词：
Diabetes mellitus; Hemoglobin A1c; Lung cancer; Interstitial lung disease; Advanced glycation end product; Glucose intolerance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：857 / 865
页数：8
相关论文
共 50 条
  • [1] Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
    Otani, Toshihito
    Yamaguchi, Kakuhiro
    Nakao, Satoshi
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Miyamoto, Shintaro
    Nakashima, Taku
    Iwamoto, Hiroshi
    Fujitaka, Kazunori
    Hamada, Hironobu
    Hattori, Noboru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (05) : 857 - 865
  • [2] Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
    Nakao, Satoshi
    Yamaguchi, Kakuhiro
    Iwamoto, Hiroshi
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Miyamoto, Shintaro
    Nakashima, Taku
    Ohshimo, Shinichiro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Hattori, Noboru
    RESPIRATORY MEDICINE, 2020, 172
  • [3] Chemotherapy-induced lung disease
    Limper, AH
    CLINICS IN CHEST MEDICINE, 2004, 25 (01) : 53 - +
  • [4] Characteristics of and Risk Factors for Interstitial Lung Disease Induced by Chemotherapy for Lung Cancer
    Sakurada, Takumi
    Kakiuchi, Soji
    Tajima, Soichiro
    Horinouchi, Yuya
    Okada, Naoto
    Nishisako, Hirotaka
    Nakamura, Toshimi
    Teraoka, Kazuhiko
    Kawazoe, Kazuyoshi
    Yanagawa, Hiroaki
    Nishioka, Yasuhiko
    Minakuchi, Kazuo
    Ishizawa, Keisuke
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (04) : 398 - 404
  • [5] Association Between Interstitial Lung Disease and Outcomes After Lung Cancer Resection
    Axtell, Andrea L.
    David, Elizabeth A.
    Block, Mark I.
    Parsons, Niharika
    Habib, Robert
    Muniappan, Ashok
    ANNALS OF THORACIC SURGERY, 2023, 116 (03): : 533 - 541
  • [6] Chemotherapy-Induced Pulmonary Toxicity in Lung Cancer Patients
    Ryu, Jay H.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (09) : 1313 - 1314
  • [7] Predictive factors for severe radiation-induced lung injury in patients with lung cancer and coexisting interstitial lung disease
    Park, Shin-Hyung
    Lim, Jae-Kwang
    Kang, Min Kyu
    Park, Jongmoo
    Hong, Chae Moon
    Kim, Chang Ho
    Cha, Seung Ick
    Lee, Jaehee
    Lee, Seoung-Jun
    Kim, Jae-Chul
    RADIOTHERAPY AND ONCOLOGY, 2024, 192
  • [8] Re-administration of Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer Who Recovered from Chemotherapy-induced Interstitial Lung Disease
    Kashiwabara, Kosuke
    Semba, Hiroshi
    Fujii, Shinji
    Tsumura, Shinsuke
    IN VIVO, 2018, 32 (04): : 851 - 857
  • [9] Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer
    Ozawa, Yuichi
    Akahori, Daisuke
    Koda, Keigo
    Abe, Takefumi
    Hasegawa, Hirotsugu
    Matsui, Takashi
    Tanahashi, Masayuki
    Niwa, Hiroshi
    Yamada, Kazunari
    Yokomura, Koshi
    Suda, Takafumi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (05) : 1031 - 1038
  • [10] Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer
    Yuichi Ozawa
    Daisuke Akahori
    Keigo Koda
    Takefumi Abe
    Hirotsugu Hasegawa
    Takashi Matsui
    Masayuki Tanahashi
    Hiroshi Niwa
    Kazunari Yamada
    Koshi Yokomura
    Takafumi Suda
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1031 - 1038
12345